HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply

BACKGROUND: Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA-antibody screening was implemented in different strategies. METHODS: Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA-antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA-antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD-negative and RhD-positive donors. RESULTS: The model calculated that there would be 222,239 RhD-negative male and 74,655 nulliparous RhD-negative female donors. If all group O RhD-negative parous females were screened, 109,479 were calculated to not be HLA-sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD-negative females ≥50 years were screened, 59,138 donors would not be HLA-sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD-negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA-sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD-positive males and females were modeled. CONCLUSION: HLA-antibody screening realizes additional LTOWB donors.

Authors

Institutions

Publication Details

Journal
Transfusion
Published
2026-11-14
DOI
https://doi.org/10.1111/trf.70485
Primary Topic
Blood donation and transfusion practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply

Jansen N. Seheult, Emil Ainsworth Jochumsen, Casey Vieni, Ulrik Sprogøe et al.
Transfusion
Blood donation and transfusion practices
article

HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply

Jansen N. Seheult, Emil Ainsworth Jochumsen, Casey Vieni, Ulrik Sprogøe, Mark Harris Yazer, Audra Taylor, Samantha Ngamsuntikul
article en

Abstract

BACKGROUND: Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA-antibody screening was implemented in different strategies. METHODS: Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA-antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA-antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD-negative and RhD-positive donors. RESULTS: The model calculated that there would be 222,239 RhD-negative male and 74,655 nulliparous RhD-negative female donors. If all group O RhD-negative parous females were screened, 109,479 were calculated to not be HLA-sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD-negative females ≥50 years were screened, 59,138 donors would not be HLA-sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD-negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA-sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD-positive males and females were modeled. CONCLUSION: HLA-antibody screening realizes additional LTOWB donors.

Transfusion
Mayo Clinic (US), University of Pittsburgh (US), University of Utah (US), Odense University Hospital (DK), South Texas Blood and Tissue Center (US)
Blood donation and transfusion practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon